Skip to main navigation Skip to search Skip to main content

Neue HER2-zielgerichtete Therapieoption für vorbehandelte Patientinnen mit metastasiertem Mammakarzinom

Translated title of the contribution: A new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer

M. Banys-Paluchowski*

*Corresponding author for this work
Translated title of the contributionA new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer
Original languageGerman
JournalOnkologe
Volume26
Issue number6
Pages (from-to)561-563
Number of pages3
ISSN0947-8965
DOIs
Publication statusPublished - 01.06.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

Cite this